Addus HomeCare (ADUS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
19 May, 2026Executive summary
Net service revenues rose 7.7% year-over-year to $363.6 million for Q1 2026, driven by growth in personal care and hospice segments, partially offset by a decline in home health revenues.
Net income increased 18.1% to $25.1 million, with adjusted EPS up 14.1% to $1.62 and adjusted EBITDA up 9.7% to $44.5 million.
Cash flow from operations was $52.4 million, with cash on hand of $103.1 million and reduced bank debt to $94.3 million.
Closed acquisition of HomeCourt Home Care in Indiana and signed a definitive agreement for another Indiana acquisition, both expected to be immediately accretive.
Growth supported by positive hiring trends, operational improvements, and favorable reimbursement rate changes in key states.
Financial highlights
Personal care segment revenue grew 8.8% to $281.1 million (77.3% of total revenue), with 6.5% organic growth and higher revenue per billable hour.
Hospice revenue was $65.8 million (18.1% of revenue), with 7.7% organic growth and improved average daily census.
Home health revenue was $16.7 million (4.6% of revenue), with improved operating income despite a year-over-year revenue decline.
Gross margin remained stable at 31.9% year-over-year; adjusted EBITDA margin was 12.2%.
Adjusted net income per diluted share was $1.62, excluding $0.06 in acquisition expenses and $0.20 in non-cash stock-based compensation.
Outlook and guidance
Expect gross margin and adjusted EBITDA margin to remain stable and above 12% for the full year.
Anticipate continued growth in personal care and hospice, with same-store personal care hours per business day targeted at 2–2.5%.
Home health expected to return to growth in the second half of 2026, supported by new leadership and sales initiatives.
Management expects continued organic growth and value from acquisitions in 2026, with optimism for further expansion and synergies across care segments.
Targeting at least 10% annual revenue growth, benefiting from demographic trends and managed care expansion.
Latest events from Addus HomeCare
- Q2 2026 revenue rose 8% to $377.4M, with net income up 25.2% and strong cash flow fueling growth.ADUS
Q2 2026 - All agenda items, including director elections and auditor ratification, were approved.ADUS
AGM 2026 - PCS growth, tech adoption, and M&A drive expansion amid stable regulatory and financial outlook.ADUS
RBC Capital Markets Global Healthcare Conference 2026 - Census and hours growth accelerate with tech adoption, supporting balanced expansion and M&A.ADUS
Bank of America Global Healthcare Conference 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing - Q3 revenue up 7%, EPS up 13%, Gentiva deal to close Q4, New York exit, liquidity strong.ADUS
Q3 2024 - Q2 revenue up 10.4%, net income up 21.7%, and $350M Gentiva acquisition announced.ADUS
Q2 2024 - Regulatory clarity, strong hiring, and M&A focus drive growth and expansion plans.ADUS
Jefferies 2024 Global Healthcare Conference - Q1 2025 delivered 20% revenue growth and margin gains, led by personal care and acquisitions.ADUS
Q1 2025